Details:

The first administration of a new investigational medicinal product in human beings is a very

important step in the development of a new drug. The transition from non-clinical to early

clinical development marks a milestone in the destiny of the compound.

A Spanish medical biotechnology SME dedicated to promoting health in the community

understands this process and its experts in safety assessment know how to give support

and assistance at all stages. An experienced team of technical and scientific experts as

well as program and regulatory affairs managers are able to design an entire drug

development program, or individual studies, to complement requested in-house capabilities.

The Spanish company offers specialized services including renal disease and hypertension

 to perform in-depth studies related to:

- Preclinical pharmacology, toxicology and physiopathology at all experimental levels:

animal models, isolated organ studies, cellular and molecular biology. 

- Specific clinical studies carried out within a network of contacts including national and

international hospitals as well as private and public foundations.

Pioneering systems for a new concept regarding preventive and personalized clinical

management of renal diseases and hypertension based on revolutionary urinary

markers that indicate the oncoming disease are offered. These systems consist on a

conceptually innovative pharmaceutical discovery program for the prevention and

treatment of acute kidney injury, chronic renal disease and hypertension consisting

 of therapies selectively targeted towards points of action.

The company also offers contract research services tailored to specific needs.

Services provided are specialized in pathophysiological studies at the whole animal,

 cell and molecular levels, mainly in acute and chronic renal diseases and hypertension,

 but also in other diseases with high human and socioeconomic impact such as diabetes

 and cancer.

The company provides a truly integrated service for new chemical entities, biological

and phytopharmaceuticals from strategic development planning, through project

performance, up to dossier preparation for clinical trial authorization or product

registration.

Type and Role of Partner Sought:

 The Spanish company is open to partnering and servicing research groups and other

 companies in the drug discovery and diagnostics fields through commercial agreements

 with technical assistance, licence agreements and technical cooperation agreements.

 Scientific-technical consultancy to the biotechnology and pharmaceutical industry

as well as to non-profit organizations and individual researchers in the field of drug

discovery and diagnostics, pathophysiological mechanisms, toxicology and pharmaceutical

 technology is offered. Potential partners should be those seeking for innovative solutions

 for the prevention, identification, diagnosis, treatment, evaluation and monitoring of

 diseases. Also investors and business decision-makers needing specific information to

 make strategic decisions.